Late gadolinium enhancement imaging and sudden cardiac death
Top Cited Papers
Open Access
- 16 July 2025
- journal article
- Published by Oxford University Press (OUP) in European Heart Journal
- Vol. 46 (36) , 3555-3568
Abstract
The prediction and management of sudden cardiac death risk continue to pose significant challenges in cardiovascular care despite advances in therapies over the last two decades. Late gadolinium enhancement (LGE) on cardiac magnetic resonance—a marker of myocardial fibrosis—is a powerful non-invasive tool with the potential to aid the prediction of sudden death and direct the use of preventative therapies in several cardiovascular conditions. In this state-of-the-art review, we provide a critical appraisal of the current evidence base underpinning the utility of LGE in both ischaemic and non-ischaemic cardiomyopathies together with a focus on future perspectives and the role for machine learning and digital twin technologies.Keywords
Funding Information
- British Heart Foundation
- MRC
- Alexander Jansons Myocarditis UK
- Rosetrees Trust
This publication has 171 references indexed in Scilit:
- Early Intervention in Patients With Asymptomatic Severe Aortic Stenosis and Myocardial FibrosisJAMA, 2025
- Risk Stratification in Nonischemic Dilated Cardiomyopathy Using CMR ImagingJAMA, 2024
- Myocardial Scarring and Sudden Cardiac Death in Young Patients With Hypertrophic CardiomyopathyJAMA Cardiology, 2024
- Diagnosis and Treatment of Acute MyocarditisJAMA, 2023
- Mortality Among Referral Patients With Hypertrophic Cardiomyopathy vs the General European PopulationJAMA Cardiology, 2020
- Association of Titin-Truncating Genetic Variants With Life-threatening Cardiac Arrhythmias in Patients With Dilated Cardiomyopathy and Implanted DefibrillatorsJAMA Network Open, 2019
- Cardiac Fibrosis and Arrhythmogenesis2017
- ESC sudden‐death risk model in hypertrophic cardiomyopathy: Incremental value of quantitative contrast‐enhanced CMR in intermediate‐risk patientsClinical Cardiology, 2017
- Association of Fibrosis With Mortality and Sudden Cardiac Death in Patients With Nonischemic Dilated CardiomyopathyJAMA, 2013
- Implantable Defibrillators for the Prevention of Mortality in Patients With Nonischemic CardiomyopathyJAMA, 2004